A new vaccine targeting mosquito saliva proteins proved safe and prompted a strong immune response in humans, moving scientists one step closer to halting the transmission of all mosquito-borne pathogens.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.